We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

81 hedge funds and large institutions have $895M invested in Orchard Therapeutics plc American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

53% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 17

31% more funds holding

Funds holding: 62 → 81 (+19)

18% more capital invested

Capital invested by funds: $755M → $895M (+$139M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
81
Holders Change
+19
Holders Change %
+30.65%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
26
Reduced
17
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$27.7M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$22.1M
3
JP Morgan Chase
JP Morgan Chase
New York
+$17.8M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$14.6M
5
RCM
RA Capital Management
Massachusetts
+$14.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$98.9M
2
PI
Putnam Investments
Massachusetts
-$11.8M
3
FCMI
Foresite Capital Management IV
California
-$6.63M
4
PA
Perceptive Advisors
New York
-$6.2M
5
CAM
Cormorant Asset Management
Massachusetts
-$3.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$169M -$98.9M -813,459 -40%
DM
2
Deerfield Management
New York
$122M -$746K -6,135 -0.7%
RCM
3
RA Capital Management
Massachusetts
$87.9M +$14.2M +116,542 +22%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$75.2M +$6.26M +51,478 +10%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$51.4M +$4.63M +38,100 +11%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$44.3M +$27.7M +227,910 +242%
CA
7
CHI Advisors
New York
$40.7M -$386K -3,172 -1%
Baillie Gifford & Co
8
Baillie Gifford & Co
United Kingdom
$37.7M +$22.1M +181,500 +196%
Artisan Partners
9
Artisan Partners
Wisconsin
$37M +$11.5M +94,444 +54%
Federated Hermes
10
Federated Hermes
Pennsylvania
$30.9M +$14.6M +120,000 +114%
DCM
11
Driehaus Capital Management
Illinois
$20.3M +$155K +1,277 +0.9%
JP Morgan Chase
12
JP Morgan Chase
New York
$20.2M +$17.8M +146,599 New
ACH
13
ArrowMark Colorado Holdings
Colorado
$18M +$5.79M +47,617 +57%
Temasek Holdings
14
Temasek Holdings
Singapore
$13.8M – – –
ECM
15
Element Capital Management
New York
$13.4M +$11.8M +97,162 New
CC
16
Casdin Capital
New York
$11.3M +$6.2M +51,000 +165%
Westfield Capital Management
17
Westfield Capital Management
Massachusetts
$10.5M -$3.83M -31,516 -29%
Massachusetts Financial Services
18
Massachusetts Financial Services
Massachusetts
$7.01M +$1.82K +15 +0%
Citadel Advisors
19
Citadel Advisors
Florida
$6.96M -$1.7M -13,998 -22%
New York State Common Retirement Fund
20
New York State Common Retirement Fund
New York
$6.25M +$1.86M +15,305 +51%
BBA
21
Baker Bros. Advisors
New York
$5.58M – – –
BlackRock
22
BlackRock
New York
$5.2M +$4.6M +37,794 New
CAM
23
Cormorant Asset Management
Massachusetts
$4.82M -$3.95M -32,513 -48%
AG
24
Artal Group
Luxembourg
$4.81M – – –
PC
25
Polar Capital
United Kingdom
$4.81M – – –
1
2 3 4

ORTX Hedge Fund Activity: Q4 2019 in Review

81 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q4 2019, worth a combined $895M — up 18% from $755M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ORTX positions and 10 closed out — a net gain of 19 holders — while 26 added to existing stakes and 17 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $27.7M. The largest seller was Fidelity Investments, cutting an estimated $98.9M.

  • 81 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q4 2019, up from 62 in Q3 2019.
  • Funds reported $895M of Orchard Therapeutics plc American Depositary Shares stock for Q4 2019, up 18% quarter-over-quarter.
  • 29 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q4 2019 and 10 closed out, a net change of +19 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q4 2019 was Wellington Management Group, an estimated $27.7M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q4 2019 was Fidelity Investments, an estimated $98.9M sold.

Based on aggregated 13F filings for Q4 2019.